scholarly journals TCT-35 Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3 Year Clinical Results of the ABSORB Cohort B1 Trial

2012 ◽  
Vol 60 (17) ◽  
pp. B11 ◽  
Author(s):  
Peter Smits
Sign in / Sign up

Export Citation Format

Share Document